Search

Displaying results 1911 - 1920 of 10000 in total
  1. Drug

    Motavizumab

    go.drugbank.com/drugs/DB06310
    Investigational

  2. Drug

    BNC105

    go.drugbank.com/drugs/DB06313
    Investigational

    Categories: Heterocyclic Compounds, 2-Ring
  3. Drug

    SGX-523

    go.drugbank.com/drugs/DB06314
    Investigational

    A MET receptor tyrosine kinase inhibitor.

    Synonyms: 6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinolineCategories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Elotuzumab

    go.drugbank.com/drugs/DB06317
    ApprovedInvestigational

    Elotuzumab targets SLAMF7, also known as Signaling Lymphocytic Activation Molecule Family member 7, a cell surface glycoprotein. … Elotuzumab is marketed under the brand Empliciti™ by Bristol-Myers Squibb.

  5. Drug

    AZX-100

    go.drugbank.com/drugs/DB06323
    Investigational

  6. Drug

    XmAb 2513

    go.drugbank.com/drugs/DB06324
    Investigational

    XmAb 2513 is a humanized monoclonal antibody that targets the antigen CD30, a molecule expressed on the surface of a number of tumor cell types.

  7. Drug

    Latiglutenase

    go.drugbank.com/drugs/DB06326
    Investigational

  8. Drug

    RG-7795

    go.drugbank.com/drugs/DB06329
    Investigational

  9. Drug

    4-O-Demethylpenclomedine

    go.drugbank.com/drugs/DB06331
    Experimental

    Synonyms: 4-Dmpen, 4-Dm-penCategories: Heterocyclic Compounds, 1-Ring
  10. Drug

    Tucidinostat

    go.drugbank.com/drugs/DB06334
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring